ATI RN Pharmacology 2023 III | Nurselytic

Questions 69

ATI RN

Home > ATI RN > ATI Pharmacology > ATI RN Pharmacology 2023 III
ATI RN Test Bank

ATI RN Pharmacology 2023 III Questions

Extract:


Question 1 of 5

A nurse is caring for a client who has major depressive disorder and a prescription for venlafaxine. For which of the following findings should the nurse notify the provider?

Correct Answer: C

Rationale: The correct answer is C: Hypertension. Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that can increase blood pressure. Notify the provider to address potential adverse effects. Bradycardia (
A) is not typically associated with venlafaxine. Tachypnea (
B) and hypothermia (
D) are not common side effects of the medication.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

A nurse in an emergency department is administering naloxone to a client who is experiencing opioid toxicity. Following administration of the medication, which of the following should the nurse assess first?
A nurse is caring for a client who is receiving parenteral nutrition and identifies that the client has hypoglycemia. Which of the following actions should the nurse take?
A nurse is caring for a client who has received propofol during a colonoscopy. The nurse should monitor for which of the following as an adverse effect of the medication?
A nurse is reviewing a provider's prescriptions for medications. Which of the following prescriptions should the nurse clarify with the provider?
A nurse is assessing a client who is receiving a peripheral IV infusion and notes infiltration of fluid into the tissues surrounding the insertion site. Which of the following actions should the nurse take?

Access More Questions!

ATI RN Basic

$89/ 30 days

 

ATI RN Premium

$150/ 90 days